Daniel Yazbeck is on a mission to help people Trust & Verify what they put into their minds and bodies. He founded the Yazbeck Consulting & Investment Group in 2007, which later became the seed investor in CDx, Inc – the makers of MyDx, the world’s first handheld chemical analyzer that will empower end consumers to test the safety and potency of everything they eat, drink and inhale. Daniel comes with over 13 years of experience helping some of the top Fortune 500 companies grow, including Pfizer Pharmaceuticals as a Scientist specializing in Chemical R&D Technologies as well as Panasonic, spearheading their new Market, Business and Strategic Product Development activities in the consumer electronics healthcare field. Daniel holds a Master’s Degree in Medicinal Chemistry from McGill University, with a minor in Marketing, and is an inventor and author on several world patents and research publications. To learn more, please visitwww.yazbeckinvestments.com.